Literature DB >> 33578816

Dopamine Receptors and the Kidney: An Overview of Health- and Pharmacological-Targeted Implications.

Alejandro Olivares-Hernández1,2, Luis Figuero-Pérez1,2, Juan Jesus Cruz-Hernandez2, Rogelio González Sarmiento2,3, Ricardo Usategui-Martin4,5,6, José Pablo Miramontes-González2,5,7.   

Abstract

The dopaminergic system can adapt to the different physiological or pathological situations to which the kidneys are subjected throughout life, maintaining homeostasis of natriuresis, extracellular volume, and blood pressure levels. The role of renal dopamine receptor dysfunction is clearly established in the pathogenesis of essential hypertension. Its associations with other pathological states such as insulin resistance and redox balance have also been associated with dysfunction of the dopaminergic system. The different dopamine receptors (D1-D5) show a protective effect against hypertension and kidney disorders. It is essential to take into account the various interactions of the dopaminergic system with other elements, such as adrenergic receptors. The approach to therapeutic strategies for essential hypertension must go through the blocking of those elements that lead to renal vasoconstriction or the restoration of the normal functioning of dopamine receptors. D1-like receptors are fundamental in this role, and new therapeutic efforts should be directed to the restoration of their functioning in many patients. More studies will be needed to allow the development of drugs that can be targeted to renal dopamine receptors in the treatment of hypertension.

Entities:  

Keywords:  dopamine; hypertension; kidney

Mesh:

Substances:

Year:  2021        PMID: 33578816      PMCID: PMC7916607          DOI: 10.3390/biom11020254

Source DB:  PubMed          Journal:  Biomolecules        ISSN: 2218-273X


  142 in total

1.  Regulation of renalase expression by D5 dopamine receptors in rat renal proximal tubule cells.

Authors:  Shaoxiong Wang; Xi Lu; Jian Yang; Hongyong Wang; CaiYu Chen; Yu Han; Hongmei Ren; Shuo Zheng; Duofen He; Lin Zhou; Laureano D Asico; Wei Eric Wang; Pedro A Jose; Chunyu Zeng
Journal:  Am J Physiol Renal Physiol       Date:  2014-02-05

2.  The role of intrarenal nitric oxide in the natriuretic response to dopamine-receptor activation.

Authors:  U Venkatakrishnan; C Chen; M F Lokhandwala
Journal:  Clin Exp Hypertens       Date:  2000-04       Impact factor: 1.749

3.  Glomerular hyperfiltration in experimental diabetes mellitus: potential role of tubular reabsorption.

Authors:  V Vallon; K Richter; R C Blantz; S Thomson; H Osswald
Journal:  J Am Soc Nephrol       Date:  1999-12       Impact factor: 10.121

Review 4.  Oxidants, antioxidants, and the degenerative diseases of aging.

Authors:  B N Ames; M K Shigenaga; T M Hagen
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-01       Impact factor: 11.205

5.  A physiological role for the dopamine D5 receptor as a regulator of BDNF and Akt signalling in rodent prefrontal cortex.

Authors:  Melissa L Perreault; Jace Jones-Tabah; Brian F O'Dowd; Susan R George
Journal:  Int J Neuropsychopharmacol       Date:  2012-07-25       Impact factor: 5.176

Review 6.  Theodore Cooper Lecture: Renal dopamine system: paracrine regulator of sodium homeostasis and blood pressure.

Authors:  R M Carey
Journal:  Hypertension       Date:  2001-09       Impact factor: 10.190

7.  Postglomerular vasoconstriction induced by dopamine D(3) receptor activation in anesthetized rats.

Authors:  G Luippold; S Schneider; V Vallon; H Osswald; B Mühlbauer
Journal:  Am J Physiol Renal Physiol       Date:  2000-04

Review 8.  Renal dopamine and angiotensin II receptor signaling in age-related hypertension.

Authors:  Gaurav Chugh; Indira Pokkunuri; Mohammad Asghar
Journal:  Am J Physiol Renal Physiol       Date:  2012-10-24

9.  Role of the D1A dopamine receptor in the pathogenesis of genetic hypertension.

Authors:  F E Albrecht; J Drago; R A Felder; M P Printz; G M Eisner; J E Robillard; D R Sibley; H J Westphal; P A Jose
Journal:  J Clin Invest       Date:  1996-05-15       Impact factor: 14.808

10.  Evidence that intrarenal dopamine acts as a paracrine substance at the renal tubule.

Authors:  H M Siragy; R A Felder; N L Howell; R L Chevalier; M J Peach; R M Carey
Journal:  Am J Physiol       Date:  1989-09
View more
  4 in total

1.  Incidence of hospital contacts with acute kidney injury after initiation of second-generation antipsychotics in older adults: a Danish population-based cohort study.

Authors:  Reeha Sharon; Theis Lange; Mia Aakjær; Sarah Brøgger Kristiansen; Morten Baltzer Houlind; Morten Andersen
Journal:  Eur J Clin Pharmacol       Date:  2022-05-31       Impact factor: 3.064

2.  Levodopa-Carbidopa Intestinal Gel Improves Symptoms of Orthostatic Hypotension in Patients with Parkinson's Disease-Prospective Pilot Interventional Study.

Authors:  Simona Stanková; Igor Straka; Zuzana Košutzká; Peter Valkovič; Michal Minár
Journal:  J Pers Med       Date:  2022-04-29

Review 3.  SPR-Based Sensor for the Early Detection or Monitoring of Kidney Problems.

Authors:  Budi Mulyanti; Harbi Setyo Nugroho; Chandra Wulandari; Yuni Rahmawati; Lilik Hasanah; Ida Hamidah; Roer Eka Pawinanto; Burhanuddin Yeop Majlis
Journal:  Int J Biomater       Date:  2022-06-16

4.  Effects of Virgin Olive Oil on Blood Pressure and Renal Aminopeptidase Activities in Male Wistar Rats.

Authors:  Germán Domínguez-Vías; Ana Belén Segarra; Manuel Ramírez-Sánchez; Isabel Prieto
Journal:  Int J Mol Sci       Date:  2021-05-20       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.